Allogene Therapeutics (ALLO) Institutional Ownership $1.45 -0.01 (-0.68%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$1.45 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Allogene Therapeutics (NASDAQ:ALLO)CurrentInstitutional OwnershipPercentage83.63%Number ofInstitutional Buyers(last 12 months)84TotalInstitutional Inflows(last 12 months)$69.51MNumber ofInstitutional Sellers(last 12 months)38TotalInstitutional Outflows(last 12 months)$14.89M Get ALLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALLO Institutional Buying and Selling by Quarter Allogene Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/4/2025 Harold Davidson & Associates Inc.252,350$368K0.2%+8.5%0.115% 5/19/2025 Jane Street Group LLC1,116,681$1.63M0.0%+578.7%0.511% 5/16/2025 Goldman Sachs Group Inc.5,853,974$8.55M0.0%+177.9%2.677% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.286,033$418K0.0%-6.5%0.131% 5/16/2025 Curi RMB Capital LLC195,890$286K0.0%+31.0%0.090% 5/16/2025 AQR Capital Management LLC58,223$85K0.0%N/A0.027% 5/15/2025 Frazier Life Sciences Management L.P.3,868,750$5.65M0.3%+34.9%1.769% 5/15/2025 DAFNA Capital Management LLC1,380,118$2.02M0.6%+11.3%0.631% 5/14/2025 MetLife Investment Management LLC79,823$117K0.0%+110.0%0.036% 5/14/2025 Partners Capital Investment Group LLP254,845$372K0.0%+173.3%0.117% Get the Latest News and Ratings for ALLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2025 Hsbc Holdings PLC81,435$115K0.0%+17.8%0.037% 5/13/2025 Brooklyn Investment Group30,731$45K0.0%N/A0.014% 5/13/2025 Aberdeen Group plc867,250$1.27M0.0%+138.0%0.397% 5/12/2025 Nuveen LLC215,366$314K0.0%N/A0.098% 5/12/2025 Invesco Ltd.285,207$416K0.0%+123.7%0.130% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.264,065$386K0.0%+4.1%0.121% 5/9/2025 Deutsche Bank AG99,544$145K0.0%+1,416.7%0.046% 5/9/2025 Charles Schwab Investment Management Inc.1,155,844$1.69M0.0%-2.8%0.528% 5/9/2025 Raiffeisen Bank International AG402,000$623K0.0%-6.5%0.184% 5/8/2025 XTX Topco Ltd20,746$30K0.0%-86.9%0.009% 5/8/2025 GSA Capital Partners LLP483,768$706K0.1%N/A0.221% 5/6/2025 Y Intercept Hong Kong Ltd43,940$64K0.0%N/A0.020% 4/30/2025 Cerity Partners LLC380,424$555K0.0%-1.8%0.175% 4/30/2025 Moloney Securities Asset Management LLC295,000$431K0.1%N/A0.136% 4/28/2025 Vontobel Holding Ltd.185,646$271K0.0%-5.0%0.085% 4/17/2025 Exchange Traded Concepts LLC68,858$101K0.0%+13.5%0.032% 4/16/2025 Wealth Enhancement Advisory Services LLC19,260$28K0.0%N/A0.009% 4/8/2025 Rhumbline Advisers183,708$268K0.0%-4.2%0.085% 3/18/2025 California State Teachers Retirement System135,554$289K0.0%+6.0%0.065% 2/18/2025 Navalign LLC59,865$128K0.0%-20.6%0.029% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC270,559$576K0.0%+18.2%0.129% 2/17/2025 Squarepoint Ops LLC20,345$43K0.0%-89.2%0.010% 2/17/2025 Two Sigma Advisers LP2,702,200$5.76M0.0%+12.1%1.289% 2/17/2025 Two Sigma Investments LP2,712,139$5.78M0.0%-3.1%1.294% 2/17/2025 Tidal Investments LLC135,952$290K0.0%-4.8%0.065% 2/17/2025 Rafferty Asset Management LLC367,445$783K0.0%+15.9%0.175% 2/17/2025 Raiffeisen Bank International AG430,000$903K0.0%N/A0.205% 2/17/2025 ProShare Advisors LLC46,082$98K0.0%+25.6%0.022% 2/17/2025 Patient Square Capital LP1,489,909$3.17M1.2%N/A0.711% 2/17/2025Nuveen Asset Management LLC300,871$641K0.0%+18.3%0.143% Want to front-run Warren Buffett? (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now.2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.305,895$651K0.0%+23.6%0.146% 2/17/2025 Graham Capital Management L.P.41,737$89K0.0%N/A0.020% 2/17/2025 Coastal Bridge Advisors LLC221,059$471K0.1%-45.5%0.105% 2/17/2025 D. E. Shaw & Co. Inc.54,517$116K0.0%-39.6%0.026% 2/17/2025 DAFNA Capital Management LLC1,240,118$2.64M0.7%+18.1%0.591% 2/17/2025 Caption Management LLC15,000$32K0.0%N/A0.007% 2/17/2025 Brevan Howard Capital Management LP87,573$187K0.0%+38.9%0.042% 2/17/2025Caxton Associates LP206,380$440K0.0%-14.8%0.098% 2/17/2025 Bank of America Corp DE1,163,743$2.48M0.0%+99.3%0.555% 2/17/2025 BNP Paribas Financial Markets849,658$1.81M0.0%+1,732.2%0.405% 2/17/2025 Ameriprise Financial Inc.201,943$430K0.0%+14.0%0.096% 2/14/2025 Jane Street Group LLC164,523$350K0.0%-63.5%0.078% 2/14/2025 Foresite Capital Management VI LLC3,448,275$7.35M3.3%N/A1.645% 2/14/2025 Northern Trust Corp1,305,232$2.78M0.0%+4.5%0.623% 2/14/2025 Lynx1 Capital Management LP10,874,723$23.16M8.7%+75.3%5.187% 2/14/2025 Susquehanna Fundamental Investments LLC376,661$802K0.0%N/A0.180% 2/14/2025 Syon Capital LLC18,351$39K0.0%N/A0.009% 2/14/2025 Price T Rowe Associates Inc. MD4,485,572$9.56M0.0%-7.3%2.139% 2/14/2025 Hsbc Holdings PLC69,155$147K0.0%+32.0%0.033% 2/14/2025 MetLife Investment Management LLC38,020$81K0.0%-28.5%0.018% 2/14/2025 Dimensional Fund Advisors LP3,561,626$7.59M0.0%+30.4%1.699% 2/14/2025 Gilead Sciences Inc.1,156,689$2.46M0.2%N/A0.552% 2/13/2025 Zacks Investment Management480,874$1.02M0.0%-6.9%0.229% 2/13/2025 XTX Topco Ltd158,537$338K0.0%N/A0.076% 2/13/2025 Barclays PLC761,286$1.62M0.0%+122.0%0.363% 2/13/2025 Renaissance Technologies LLC554,541$1.18M0.0%-13.6%0.264% 2/13/2025 Legal & General Group Plc112,235$239K0.0%-11.9%0.054% 2/13/2025 Invesco Ltd.127,486$272K0.0%+7.0%0.061% 2/13/2025 Cerity Partners LLC387,387$832K0.0%-10.4%0.185% 2/13/2025 Wells Fargo & Company MN104,593$223K0.0%+29.4%0.050% 2/12/2025 PAX Financial Group LLC12,832$27K0.0%N/A0.006% 2/12/2025 RPO LLC14,787$31K0.0%N/A0.007% 2/12/2025 JPMorgan Chase & Co.3,736,132$7.96M0.0%-8.6%1.782% 2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.253,576$548K0.0%+7.1%0.121% 2/11/2025 Vanguard Group Inc.8,000,692$17.04M0.0%-3.9%3.816% 2/11/2025 KLP Kapitalforvaltning AS20,400$43K0.0%N/A0.010% 2/11/2025 Sei Investments Co.48,320$103K0.0%N/A0.023% 2/11/2025 American Century Companies Inc.232,356$495K0.0%+16.5%0.111% 2/11/2025 Teacher Retirement System of Texas43,877$93K0.0%+28.9%0.021% 2/11/2025 Intech Investment Management LLC71,323$152K0.0%+72.6%0.034% 2/10/2025 Primecap Management Co. CA4,927,340$10.50M0.0%-13.1%2.350% 2/10/2025 Cibc World Markets Corp12,013$26K0.0%N/A0.006% 2/10/2025 Swiss National Bank287,900$613K0.0%+8.7%0.137% 2/7/2025 HighTower Advisors LLC12,150$26K0.0%-59.0%0.006% 2/6/2025 Charles Schwab Investment Management Inc.1,188,838$2.53M0.0%+0.8%0.567% 2/4/2025 Bank of New York Mellon Corp330,769$705K0.0%+4.1%0.158% 1/31/2025 Partners Capital Investment Group LLP93,248$199K0.0%-63.4%0.044% 1/30/2025 Rhumbline Advisers191,714$408K0.0%+10.1%0.091% 1/30/2025 Vontobel Holding Ltd.195,457$416K0.0%+788.4%0.093% 1/24/2025 abrdn plc364,382$776K0.0%N/A0.174% Want to front-run Warren Buffett? (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now.1/17/2025 Bourgeon Capital Management LLC118,700$253K0.0%-16.7%0.057% 1/6/2025 Nordea Investment Management AB460,641$986K0.0%+2.1%0.220% 12/26/2024 JPMorgan Chase & Co.4,087,506$11.45M0.0%-0.9%1.949% 11/25/2024 Tidal Investments LLC142,747$400K0.0%-39.7%0.068% 11/19/2024 Barclays PLC342,973$959K0.0%+101.5%0.164% 11/16/2024 Geode Capital Management LLC3,227,104$9.04M0.0%+14.4%1.539% 11/15/2024 Barclays PLC342,973$959K0.0%+101.5%0.164% 11/15/2024 MML Investors Services LLC20,000$56K0.0%N/A0.010% 11/15/2024 Zacks Investment Management516,601$1.45M0.0%N/A0.246% 11/15/2024 EP Wealth Advisors LLC24,475$69K0.0%+125.6%0.012% (Data available from 1/1/2016 forward) ALLO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALLO shares? During the previous two years, 136 institutional investors and hedge funds held shares of Allogene Therapeutics. The most heavily invested institutionals were FMR LLC ($84.08M), Lynx1 Capital Management LP ($23.16M), State Street Corp ($19.64M), Vanguard Group Inc. ($17.04M), Primecap Management Co. CA ($10.50M), Price T Rowe Associates Inc. MD ($9.56M), and Geode Capital Management LLC ($9.04M).Learn more on ALLO's institutional investors. What percentage of Allogene Therapeutics stock is owned by institutional investors? 83.63% of Allogene Therapeutics stock is owned by institutional investors. Learn more on ALLO's institutional investor holdings. Which institutional investors have been buying Allogene Therapeutics stock? Of the 120 institutional investors that purchased Allogene Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($6.90M), Goldman Sachs Group Inc. ($3.75M), Foresite Capital Management VI LLC ($3.45M), Vanguard Group Inc. ($3.09M), Perceptive Advisors LLC ($2.73M), Price T Rowe Associates Inc. MD ($1.81M), and Patient Square Capital LP ($1.49M). How much institutional buying is happening at Allogene Therapeutics? Institutional investors have bought a total of 44,650,177 shares in the last 24 months. This purchase volume represents approximately $110.86M in transactions. Which Allogene Therapeutics major shareholders have been selling company stock? Of the 51 institutional investors that sold Allogene Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($1.23M), Vanguard Group Inc. ($1.15M), Primecap Management Co. CA ($1.10M), Vestal Point Capital LP ($700K), State Street Corp ($655.04K), BNP Paribas Financial Markets ($510.14K), and JPMorgan Chase & Co. ($388.72K). How much institutional selling is happening at Allogene Therapeutics? Institutional investors have sold a total of 9,157,392 shares in the last 24 months. This volume of shares sold represents approximately $27.07M in transactions. Related Companies AUPH Institutional Ownership CVAC Institutional Ownership MLYS Institutional Ownership PAHC Institutional Ownership RCUS Institutional Ownership WVE Institutional Ownership SNDX Institutional Ownership COLL Institutional Ownership ELVN Institutional Ownership SYRE Institutional Ownership This page (NASDAQ:ALLO) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
